Literature DB >> 20440265

Cancer-selective apoptotic effects of extracellular and intracellular Par-4.

T Shrestha-Bhattarai1, V M Rangnekar.   

Abstract

Selectivity toward cancer cells is the most desirable element in cancer therapeutics. Par-4 is a cancer cell-selective proapoptotic protein that functions intracellularly in the cytoplasmic and nuclear compartments as a tumor suppressor. Moreover, recent findings indicate that the Par-4 protein is secreted by cells, and extracellular Par-4 induces cancer cell-specific apoptosis by interaction with the cell-surface receptor GRP78. This review describes the mechanisms underlying the apoptotic effects of both extracellular and intracellular Par-4 acting through its effector domain SAC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20440265      PMCID: PMC2900490          DOI: 10.1038/onc.2010.141

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

1.  Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum.

Authors:  T Fujiwara; K Oda; S Yokota; A Takatsuki; Y Ikehara
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

2.  Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression.

Authors:  M Chakraborty; S G Qiu; K M Vasudevan; V M Rangnekar
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

3.  Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185(BCR-ABL) in hematopoietic cells.

Authors:  Natasa Kukoc-Zivojnov; Elena Puccetti; Kai U Chow; Marion Bergmann; Martin Ruthardt; Dieter Hoelzer; Paris S Mitrou; Eckhart Weidmann; Simone Boehrer
Journal:  Exp Hematol       Date:  2004-07       Impact factor: 3.084

4.  Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer.

Authors:  B G Schneider; S Y Rha; H C Chung; J C Bravo; R Mera; J C Torres; K T Plaisance; R Schlegel; C M McBride; X T Reveles; R J Leach
Journal:  Mol Pathol       Date:  2003-06

5.  Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells.

Authors:  Nadia El-Guendy; Yanming Zhao; Sushma Gurumurthy; Ravshan Burikhanov; Vivek M Rangnekar
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

6.  Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes.

Authors:  C Almoguera; D Shibata; K Forrester; J Martin; N Arnheim; M Perucho
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

Review 7.  Redefining tumour suppressor genes: exceptions to the two-hit hypothesis.

Authors:  A J W Paige
Journal:  Cell Mol Life Sci       Date:  2003-10       Impact factor: 9.261

8.  Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma.

Authors:  J T Isaacs; D S Coffey
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

9.  Dlk/ZIP kinase-induced apoptosis in human medulloblastoma cells: requirement of the mitochondrial apoptosis pathway.

Authors:  D Kögel; C Reimertz; P Mech; M Poppe; M C Frühwald; H Engemann; K H Scheidtmann; J H Prehn
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

10.  Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis.

Authors:  Wei-Xing Zong; Chi Li; Georgia Hatzivassiliou; Tullia Lindsten; Qian-Chun Yu; Junying Yuan; Craig B Thompson
Journal:  J Cell Biol       Date:  2003-07-07       Impact factor: 10.539

View more
  32 in total

1.  Systemic Par-4 inhibits non-autochthonous tumor growth.

Authors:  Yanming Zhao; Ravshan Burikhanov; Jason Brandon; Shirley Qiu; Brent J Shelton; Brett Spear; Subbarao Bondada; Scott Bryson; Vivek M Rangnekar
Journal:  Cancer Biol Ther       Date:  2011-07-15       Impact factor: 4.742

2.  A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors.

Authors:  Nikhil Hebbar; Ravshan Burikhanov; Nidhi Shukla; Shirley Qiu; Yanming Zhao; Kojo S J Elenitoba-Johnson; Vivek M Rangnekar
Journal:  Cancer Res       Date:  2017-06-16       Impact factor: 12.701

Review 3.  Emerging Bcl-2 inhibitors for the treatment of cancer.

Authors:  Asfar S Azmi; Zhiwei Wang; Philip A Philip; Ramzi M Mohammad; Fazlul H Sarkar
Journal:  Expert Opin Emerg Drugs       Date:  2010-09-03       Impact factor: 4.191

4.  Prostate apoptosis response 4 (Par-4), a novel substrate of caspase-3 during apoptosis activation.

Authors:  Parvesh Chaudhry; Mohan Singh; Sophie Parent; Eric Asselin
Journal:  Mol Cell Biol       Date:  2011-12-19       Impact factor: 4.272

5.  Comparative proteomic analysis reveals growth inhibition by 3-N-alkyloxyestradiol derivative (SERM) in prostate cancer cells.

Authors:  Jennifer E Green; John S Cooperwood; Equar Taka; Karam Fa Soliman; Carl B Goodman; Romonia Renee Reams
Journal:  Cancer Genomics Proteomics       Date:  2014 Jul-Aug       Impact factor: 4.069

Review 6.  Mechanisms of apoptosis by the tumor suppressor Par-4.

Authors:  Nikhil Hebbar; Chi Wang; Vivek M Rangnekar
Journal:  J Cell Physiol       Date:  2012-12       Impact factor: 6.384

7.  Expression of PAR-4 and PHLDA1 is prognostic for overall and disease-free survival in oral squamous cell carcinomas.

Authors:  Cláudia Malheiros Coutinho-Camillo; Silvia Vanessa Lourenço; Suely Nonogaki; José Guilherme Vartanian; Maria Aparecida Nagai; Luiz Paulo Kowalski; Fernando Augusto Soares
Journal:  Virchows Arch       Date:  2013-06-09       Impact factor: 4.064

8.  The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.

Authors:  Yinxing Liu; Misty R Gilbert; Natasha Kyprianou; Vivek M Rangnekar; Craig Horbinski
Journal:  Acta Neuropathol       Date:  2014-08-19       Impact factor: 17.088

Review 9.  A journey beyond apoptosis: new enigma of controlling metastasis by pro-apoptotic Par-4.

Authors:  Reyaz Ur Rasool; Debasis Nayak; Souneek Chakraborty; Archana Katoch; Mir Mohd Faheem; Hina Amin; Anindya Goswami
Journal:  Clin Exp Metastasis       Date:  2016-08-27       Impact factor: 5.150

10.  Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia.

Authors:  Mary K McKenna; Sunil K Noothi; Sara S Alhakeem; Karine Z Oben; Joseph T Greene; Rajeswaran Mani; Kathryn L Perry; James P Collard; Jacqueline R Rivas; Gerhard C Hildebrandt; Roger A Fleischman; Eric B Durbin; John C Byrd; Chi Wang; Natarajan Muthusamy; Vivek M Rangnekar; Subbarao Bondada
Journal:  Blood       Date:  2018-04-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.